Skip to content
Events

Details

Healthcare Global Enterprises Ltd (HCG), India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 23 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.

Join us for this webinar co-organised by HCG - The Specialist In Cancer Care, Illumina Inc and Premas Life Science where thought leaders will share their experience of the clinical utility of genomics in precision oncology. The purpose of this webinar is to raise awareness of what is possible in oncology, and how this will benefit patients.

Mithua Ghosh, PhD
Director - Clinical Diagnostics,
Head - Department of Molecular and Clinical Genomics,
Health Care Global Enterprises Ltd.

K. Govind Babu, MD, DM, FUICC, FASCOU
Consultant Medical Oncologist - St. Johns Medical College and Hospital,
HCG Hospitals, Bangalore

Joel Geoghegan
Manager, Sales Specialist (Oncology)
Illumina Asia-Pacific Japan
Date & Time
4 Dec. 2021
4:00 PM - 5:30 PM
Location
Online
South APAC
Affiliation
Health Care Global Enterprises Ltd, HCG Hospitals and Illumina
Sponsor
Premas Lifescience and Illumina
Presenter
Mithua Ghosh PhD, K. Govind Babu MD and Joel Geoghegan
Topic
Oncology
Watch Now

Related Events

Mar 19
GenomeStudio - Creating Custom Cluster Files
Mar 19, 2025
Using GenomeStudio software to generate custom cluster files is necessary to analyse custom microarray content. In this webinar, we discuss the basics of cluster files including when to use a custom cluster file, why custom cluster files are needed, as well as the detailed steps required to create your own custom cluster file. Learn how to cluster the SNPs on your custom array by properly filtering and manually editing the file.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.